Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second-quarter ...

On August 4, Tom Lee, co-founder and managing partner of Fundstrat Capital, and chairman of BitMine, joined CNBC Television ...

Summit Therapeutics Inc.'s valuation hinges on ivonescimab's potential, yet the data, competition, and regulatory issues ...

The highest-paying dividend stocks in the Dow Jones Industrial Average right now are Verizon Communications (NYSE: VZ), ...

German science and technology firm Merck is showcasing its latest materials innovations at K-Display 2025 in Seoul, ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

LASCO Distributors reported a 15.3 per cent drop in net profit to $304 million for Q1 2025/26, with revenues dipping slightly ...

It’s a bad time to try to predict future pharmaceutical prices.

JCD Group has, in recent years, completed 440,000 sq. ft of new buildings in Blarney Business Park with occupiers including ...

Women with an advanced form of womb cancer have been given fresh hope after a new treatment was given the green light for ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.